Literature DB >> 2119401

Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986.

D A Caugant1, P Bol, E A Høiby, H C Zanen, L O Frøholm.   

Abstract

Serogroup B isolates of Neisseria meningitidis recovered from 278 patients with systemic disease in the Netherlands between 1958 and 1986 were analyzed with respect to serotype and multilocus enzyme genotype. Of the isolates, 28% were serotype 2b and 53% were neither serotypeable nor serosubtypeable. There were 145 distinct multilocus genotypes (electrophoretic types, ETs), with up to 31 isolates belonging to the same ET. Temporal changes in the genotypic composition of meningococcal populations in the Netherlands were demonstrated by the recent occurrence of disease caused by three clone lineages, I, III, and VI, that were not found before 1975. The epidemic of 1966-1967 and the hyperendemic wave of 1972 were caused, in large part, by two closely related but distinct clones of serotype 2b isolates, ET-11 and ET-17, respectively. Deviations in male-to-female ratio and age distribution of patients were observed for disease caused by isolates of individual clone lineages.

Entities:  

Mesh:

Year:  1990        PMID: 2119401     DOI: 10.1093/infdis/162.4.867

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  36 in total

1.  NmeSI restriction-modification system identified by representational difference analysis of a hypervirulent Neisseria meningitidis strain.

Authors:  A Bart; Y Pannekoek; J Dankert; A van der Ende
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Multilocus restriction typing method to predict the sequence type of meningococci.

Authors:  Kristin H Dyet; Robin S Simmonds; Diana R Martin
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

3.  Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway.

Authors:  Siamak P Yazdankhah; Paula Kriz; Georgina Tzanakaki; Jenny Kremastinou; Jitka Kalmusova; Martin Musilek; Torill Alvestad; Keith A Jolley; Daniel J Wilson; Noel D McCarthy; Dominique A Caugant; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

4.  Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic.

Authors:  K H Dyet; D R Martin
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

5.  Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001.

Authors:  Raymond Sw Tsang; Susan G Squires; Wendell D Zollinger; Fraser E Ashton
Journal:  Can J Infect Dis       Date:  2002-11

Review 6.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

7.  Molecular epidemiology of recent belgian isolates of Neisseria meningitidis serogroup B.

Authors:  M Van Looveren; P Vandamme; M Hauchecorne; M Wijdooghe; F Carion; D A Caugant; H Goossens
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

8.  Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains.

Authors:  B Rokbi; M Mignon; G Maitre-Wilmotte; L Lissolo; B Danve; D A Caugant; M J Quentin-Millet
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

9.  Heterogeneity of tbpB, the transferrin-binding protein B gene, among serogroup B Neisseria meningitidis strains of the ET-5 complex.

Authors:  B Rokbi; M Mignon; D A Caugant; M J Quentin-Millet
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

10.  High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985-2002.

Authors:  I Smith; D A Caugant; E A Høiby; T Wentzel-Larsen; A Halstensen
Journal:  Epidemiol Infect       Date:  2006-05-02       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.